HDII Financials 07/15/2014 18:50:47 Hypertension

HDII Financials 07/15/2014 18:50:47
Hypertension Diagnostics, Inc.
Period Ending Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 3,158 - 1,384
Cost of Revenue 3,270 - (20)
Gross Profit (112) - 1,404
Operating Expenses
Research and Development - - -
Sales, General and Admin. 1,249 366 2,403
Non-Recurring Items - - -
Other - - -
Operating Income (1,360) (366) (999)
Income From Continuing Operations
Add'l Income/Expense Items 32 11 9
Earnings Before Interest and Tax (1,329) (355) (990)
Interest Expense 144 - -
Earnings Before Tax (1,472) (355) (990)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,472) (355) (990)
Non Recurring Events
Discontinued Operations 209 761 -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,263) 406 (990)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,263) 406 (990)